The business of cell and gene therapy is as diverse as the patients which it serves and for that there is no one size fits all solution.
C> members have identified six pre-competitive common interest challenges, addressing these challenges will help to avoid multiple industry solutions
- High-level analytics
- Regulatory strategy
- Raw material sourcing and supply
- Environmental health and safety